Key Financial Data Of Group

Chordia Therapeutics,Inc - Filing #7315839

Concept As at
2024-05-31
2024-03-01 to
2024-05-31
2023-09-01 to
2024-05-31
As at
2023-08-31
2022-09-01 to
2023-08-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-1,175,664,000 JPY
225,761,000 JPY
Net assets
3,323,402,000 JPY
4,500,881,000 JPY
Total assets
3,462,039,000 JPY
4,909,123,000 JPY
Basic earnings (loss) per share
-6.64
-20.86
3.96
Diluted earnings per share
Equity-to-asset ratio
0.952 xbrli:pure
0.912 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.